Stanley T. Crooke, M.D., Ph.D. is founder, chairman and CEO of n-Lorem Foundation, a nonprofit focused on discovery, developing and providing personalized, experimental treatments for nano-rare patients (1 to 30 patients worldwide).

Prior, Dr. Crooke founded, was Chairman, CEO and Lead Scientist of Ionis Pharmaceuticals, where he led the scientific development of a new platform for drug discovery, antisense oligonucleotide (ASO) technology and the creation of one of the largest development pipelines in the biotechnology industry.

Dr. Crooke has received a number of awards, most recently, the Indiana University School of Medicine Steven C. Beering Award, the Prix Galien Roy Vagelos Pro Bono Humanum Award, the American Chemical Society’s E.B. Hershberg Award for Important Discoveries in Medicinally Active Substances, the Lifetime Achievement Award presented by the Oligonucleotide Therapeutics Society, the Scrip Lifetime Achievement Award and the 2019 Massry Prize.

He received his M.D. and Ph.D. degrees and house staff training at Baylor College of Medicine, where he currently serves on the Board of Advisors.  He has published >600 scientific publications, edited more than 20 books, has numerous patents, and led the development of more than 23 commercialized drugs.